| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 2ZUL6758TZ |
| InChI Key | XIESSJVMWNJCGZ-VKJFTORMSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H18O3 |
| Molecular Weight | 282.34 |
| AlogP | 4.12 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 49.69 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Estrogen receptor beta agonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | -6.843-26.71 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -3.68-13.98 | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 1
|
19.4 | 1216 | - | 2.29-2.7 | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 2
|
0.66 | 5 | - | 0.17-0.19 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Prostatic Hyperplasia | 2 | D011470 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL278703 |
| DrugBank | DB07933 |
| EPA CompTox | DTXSID70201547 |
| FDA SRS | 2ZUL6758TZ |
| PDB | I0G |
| PubChem | 10286159 |
| SureChEMBL | SCHEMBL14102383 |
| ZINC | ZINC000012353762 |